Nanosuspension formulations for low-soluble drugs : Pharmacokinetic evaluation using spironolactone as model compound

Journal article

Peer reviewed

P Langguth, A Hanafy, D Frenzel, P Grenier, A Nhamias, T Ohlig, G Vergnault and H SPAHN-LANGGUTH

Drug development and industrial pharmacy, Vol.31(3), pp.319-329

03/2005

PMID: 15830727

Abstract

Biological and medical sciences

General pharmacology

Medical sciences

Pharmaceutical technology. Pharmaceutical industry

Pharmacology. Drug treatments

1 Record Views

Title: Nanosuspension formulations for low-soluble drugs : Pharmacokinetic evaluation using spironolactone as model compound
Creators - without role: P Langguth - Department of Biopharmaceutics and Pharmaceutical Technology, University of Mainz, Mainz, Germany
A Hanafy - Luther University
D Frenzel - Luther University
P Grenier - Skyepharma AG, Muttenz, Switzerland
A Nhamias - Skyepharma AG, Muttenz, Switzerland
T Ohlig - Department of Biopharmaceutics and Pharmaceutical Technology, University of Mainz, Mainz, Germany
G Vergnault - Skyepharma AG, Muttenz, Switzerland
H SPAHN-LANGGUTH - Luther University
Publication Details: Drug development and industrial pharmacy, Vol.31(3), pp.319-329
Publisher: Taylor & Francis
Identifiers: 9937272008331
Academic Unit: King Abdulaziz University
Language: English
Resource Type: Journal article